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SUMMARY. The purpose of the present study was to develop and optimize floating-bioadhesive bilayer
gastroretentive drug delivery system (GRDDS) exhibiting a unique combination of floatation and bioadhe-
sion to prolong residence in the stomach using captopril (CP) and hydrochlorothiazide (HCTZ) as a model
drug. Captopril being unstable in intestinal pH and HCTZ has specific absorption from duodenum and
the first part of the jejunum and to a small extent in the stomach are suitable candidate for GRDDS. 32
factorial design was employed in formulating and optimizing the GRDDS for bilayer tablet of CP and
HCTZ matrix tablet. The main effect and interaction terms were quantitatively evaluated using a mathe-
matical model. The gastroretentive ability of the tablets was evaluated by X-radiographic studies in
healthy human volunteer. The tablet releases CP and HCTZ for extended period up to 24 h in controlled
manner. The predicted values agreed well with the experimental values and the results demonstrate the
feasibility of the optimization methodology in the development of GRDDS. The tablet was buoyant for up
to 16 h in human stomach. Development of once a day gastroretentive formulation of CP and HCTZ im-
proves the patience compliance and bioavailability of drugs. 
